Handelsavisen
prelaunch
Companies Healthcare PBH.AX
PB
PBH.AX ASX Pharmaceuticals

Pointsbet Holdings Ltd

A$0,96
Open in Charts → Attach watcher ⌖
AUD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-08-06
Ex-dividend
TR 1Y
About

Pointsbet Holdings Ltd operates in the online gaming and sports betting industry, generating revenue primarily through user wagers and commission fees on bets placed on its platform.

Business. Pointsbet Holdings Ltd (PBH.AX) is a pharmaceutical company listed on the Australian Securities Exchange. The firm operates within the Health Care sector, specifically focusing on pharmaceutical activities. No specific operating segments or headquarters locations are provided in the available data. Consequently, the company is described at the industry level as a service-revenue entity within the pharmaceuticals industry.

Classification99 %
SectorHealth Care
Industry groupPharmaceuticals
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target1,05

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
1,05
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ1 2027 earnings (confirmed · filed)2026-08-06
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
1 analysts · indicative
Ownership
Dimensional Fund Advisors, L.P.
largest disclosed fund holder
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning PBH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to PBH.AX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ1 2027 earnings (confirmed · filed)2026-08-06
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Pointsbet Holdings Ltd (PBH.AX) is a pharmaceutical company listed on the Australian Securities Exchange. The firm operates within the Health Care sector, specifically focusing on pharmaceutical activities. No specific operating segments or headquarters locations are provided in the available data. Consequently, the company is described at the industry level as a service-revenue entity within the pharmaceuticals industry.

    Classification99 %
    SectorHealth Care
    Industry groupPharmaceuticals
    AI synthesis
    GENERATED

    Pointsbet Holdings Ltd has a basic and diluted share count of 347,586,582, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

    Profitability and return metrics are not available in the current valuation snapshot, and no industry-specific preferred metrics are provided for comparison. This limits the ability to assess performance relative to industry benchmarks.

    The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to evaluate exposure to specific markets or business lines. There is no information on revenue concentration or geographic diversification.

    Growth trajectory is not quantified in the current outlook, and no numeric deltas are provided for the current or next fiscal year. Analysts have issued a mean price target of 1.05 AUD, with a strong-buy recommendation from one analyst and no other buy or hold ratings.

    Risk factors include the inability to assess liquidity risk due to missing balance-sheet data. No dilution risk is flagged, and no recent events such as filings or transcripts are provided to inform near-term risk exposure.

    No recent events, such as filings or transcripts, are available in the source data to inform the company's current strategic or operational developments.

    Key takeaways
    • Pointsbet Holdings Ltd operates in the online gaming and sports betting industry, with no immediate dilution pressure.
    • Analysts have issued a strong-buy recommendation, with a mean price target of 1.05 AUD.
    • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
    • No industry-specific metrics are available to assess performance relative to peers.
    • No geographic or segment-level revenue data is provided, limiting visibility into business diversification.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2025-08-29
    FY 2025 · Full-year highlights

    Revenue A$261.4M, +6,5% YoY; Operating income +57,0% YoY.

    RevenueA$261.4M+6,5 % YoY
    Operating income-A$18.2M+57,0 % YoY
    Net income-A$18.2M+57,1 % YoY
    Free cash flow-A$13.7M+51,4 % YoY
    EPS
    Operating cash flowA$17.1M+212,9 % YoY
    Financials
    Income statement
    RevenueA$261.4M
    Gross profitA$137.0M
    Operating income-A$18.2M
    Net income-A$18.2M
    Margins
    Gross margin52.4%
    Operating margin-7.0%
    Net margin-6.9%
    FCF margin-5.2%
    Balance sheet
    Total assetsA$73.2M
    Total liabilitiesA$67.2M
    Total equityA$6.0M
    Cash & equivalentsA$1.5M
    Long-term debtA$1.8M
    Cash flow
    Operating cash flowA$17.1M
    CapEx-A$17.9M
    Free cash flow-A$13.7M
    SBC
    P&L flow · revenue → net income
    Revenue A$261.4MOperating costs A$279.6MNet income A$18.2M
    Highlights
    • Revenue A$261.4M, +6,5% YoY
    • Operating income +57,0% YoY
    • Net income +57,1% YoY
    • Free cash flow +51,4% YoY
    • Net margin -6.9%

    Valuation FY

    Market price
    A$0,96
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships32 disclosed relationships · 2 types · extracted from filings & disclosures
    Customers2
    Amazon.Com IncAMZN.OCustomer98%Source ↗
    Walmart IncWMT.OCustomer98%Source ↗
    Subsidiaries30
    EX21:05141d8a0ff8EX21:05141d8a0ff8Subsidiarie97%
    EX21:13e2962789feEX21:13e2962789feSubsidiarie97%
    EX21:15089fd53210EX21:15089fd53210Subsidiarie97%
    EX21:1e2ea946dce5EX21:1e2ea946dce5Subsidiarie97%
    EX21:206f2f168c08EX21:206f2f168c08Subsidiarie97%
    EX21:2df6fc665857EX21:2df6fc665857Subsidiarie97%
    EX21:3758c58d5177EX21:3758c58d5177Subsidiarie97%
    EX21:3784a6402e0bEX21:3784a6402e0bSubsidiarie97%
    EX21:39a44ed3bb0dEX21:39a44ed3bb0dSubsidiarie97%
    EX21:4056a114b7d9EX21:4056a114b7d9Subsidiarie97%
    EX21:4cb314b490b4EX21:4cb314b490b4Subsidiarie97%
    EX21:5309076499faEX21:5309076499faSubsidiarie97%
    EX21:5b002098208aEX21:5b002098208aSubsidiarie97%
    EX21:660c8524cdf2EX21:660c8524cdf2Subsidiarie97%
    EX21:7036823c80e9EX21:7036823c80e9Subsidiarie97%
    EX21:73290b994f74EX21:73290b994f74Subsidiarie97%
    EX21:74dd574b9e6fEX21:74dd574b9e6fSubsidiarie97%
    EX21:7b054b04f640EX21:7b054b04f640Subsidiarie97%
    EX21:7b178c97e230EX21:7b178c97e230Subsidiarie97%
    EX21:82a3537ff0dbEX21:82a3537ff0dbSubsidiarie97%
    EX21:8a8730c6867aEX21:8a8730c6867aSubsidiarie97%
    EX21:8d4f290b744bEX21:8d4f290b744bSubsidiarie97%
    EX21:97005dd26369EX21:97005dd26369Subsidiarie97%
    EX21:97c8987c93aaEX21:97c8987c93aaSubsidiarie97%
    EX21:b6a818b89601EX21:b6a818b89601Subsidiarie97%
    EX21:bb16da494122EX21:bb16da494122Subsidiarie97%
    EX21:c6aa9d0577d6EX21:c6aa9d0577d6Subsidiarie97%
    EX21:d30b9297969eEX21:d30b9297969eSubsidiarie97%
    EX21:dc3c6a62170bEX21:dc3c6a62170bSubsidiarie97%
    EX21:e43ba08557cbEX21:e43ba08557cbSubsidiarie97%

    Supply chain

    Vendors → PBH ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSPBHPBHPointsbet Holdings Ltd32 entitiesAmazon.Com IncDepartment StoresUSWalmart IncFood Retail & DistributiUS
    2 mentions in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -0,02
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-23 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-0,02
    Revenueno estimateno estimate270,6M AUD
    Operating incomeno estimateno estimate-7,9M AUD
    Full-year consensus mean (period as reported by source) · consensus in AUD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy1
    Buy0
    Hold0
    Sell0
    Strong sell0
    12-month price targetA$1,05 · Median A$1,05
    Low A$1,05High A$1,05
    Operating income · consensus-7,9M AUD
    EPS surprise
    −76,2 %
    reported vs consensus · miss
    Revenue surprise
    −3,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowA$1,05
    MeanA$1,05
    MedianA$1,05
    HighA$1,05
    SpotA$0,96
    +9.4 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    3 %
    Base rate
    3 %
    Band
    Low
    180-day horizon · target 2027-01-21 · 1,0× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Pointsbet Holdings Ltd Market data — financials · 2026-05-28
    • Pointsbet Holdings Ltd Market data — analyst estimates · 2026-05-28
    • Pointsbet Holdings Ltd Market data — ESG · 2026-05-28

    Ownership & reference

    Top holders

    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,03 %$158M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$570M
    • MASSACHUSETTS FINANCIAL SERVICES CO /MA/Institutional Investor · as of 2026-03-310,01 %$35M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,01 %$33M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,01 %$16M
    • Jennison Associates LLCInvestment Managers · as of 2026-03-310,01 %$12M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,01 %$53M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,01 %$15M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,01 %$44M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,01 %$44M
    • Invesco QQQ TrustFunds · as of 2026-03-310,01 %$35M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,01 %$87M
    • Fisher InvestmentsInvestment Managers · as of 2026-03-310,01 %$15M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$80M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$332M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$23M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$15M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$117M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$27M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$18M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$18M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$6M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$7M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$2M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$6M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$4M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$2M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$1M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$5M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,00 %$1M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 8 sellsnet -$424K9 insiders · last 365d
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareSold 351 @ $52,28$18K · 2026-05-11
    • Lombardi Ronald M.Director, Chief Executive Officer · Common Stock, par value $0.01 per shareOther 2 543 @ $54,59$139K · 2026-05-07
    • Mekhail AdelEVP, Marketing & Sales · Common Stock, par value $0.01 per shareOther 487 @ $54,59$27K · 2026-05-07
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareOther 351 @ $54,59$19K · 2026-05-07
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareSold 305 @ $54,36$17K · 2026-05-07
    • Sacco ChristineCFO & COO · Common Stock, par value $0.01 per shareOther 991 @ $54,59$54K · 2026-05-07
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareSold 1 207 @ $54,99$66K · 2026-05-05
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareOther 307 @ $55,75$17K · 2026-05-05
    • Sacco ChristineCFO & COO · Common Stock, par value $0.01 per shareOther 1 267 @ $55,75$71K · 2026-05-05
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareSold 346 @ $55,32$19K · 2026-05-05
    • Lombardi Ronald M.Director, Chief Executive Officer · Common Stock, par value $0.01 per shareOther 2 197 @ $55,75$122K · 2026-05-05
    • Mekhail AdelEVP, Marketing & Sales · Common Stock, par value $0.01 per shareOther 4 014 · 2026-05-04
    • Lombardi Ronald M.Director, Chief Executive Officer · Common Stock, par value $0.01 per shareOther 31 468 · 2026-05-04
    • Lombardi Ronald M.Director, Chief Executive Officer · Common Stock, par value $0.01 per shareOther 19 662 · 2026-05-04
    • Lombardi Ronald M.Director, Chief Executive Officer · Common Stock, par value $0.01 per shareOther 16 789 @ $55,31$929K · 2026-05-04
    • Sacco ChristineCFO & COO · Common Stock, par value $0.01 per shareOther 7 008 · 2026-05-04
    • Sacco ChristineCFO & COO · Common Stock, par value $0.01 per shareOther 3 434 @ $55,31$190K · 2026-05-04
    • Sacco ChristineCFO & COO · Common Stock, par value $0.01 per shareOther 11 976 · 2026-05-04
    • P'Pool WilliamSee Remarks · Common Stock, par value $0.01 per shareOther 3 675 · 2026-05-04
    • P'Pool WilliamSee Remarks · Common Stock, par value $0.01 per shareOther 1 888 @ $55,31$104K · 2026-05-04
    • P'Pool WilliamSee Remarks · Common Stock, par value $0.01 per shareOther 4 187 · 2026-05-04
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareOther 2 450 · 2026-05-04
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareOther 1 243 @ $55,31$69K · 2026-05-04
    • Zerillo JeffreySenior VP Operations · Common Stock, par value $0.01 per shareOther 2 857 · 2026-05-04
    • Mekhail AdelEVP, Marketing & Sales · Common Stock, par value $0.01 per shareOther 3 505 · 2026-05-04

    Short positioning

    3.1Mshares short-3.9% vs prior
    6.65days to cover
    77.6%short of daily vol
    6fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    PBH.AXCanonical
    ASX · AUD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown
    Relationship graph
    PBHAMZN.OWMT.OEX21:051EX21:13eEX21:150EX21:1e2EX21:206EX21:2dfEX21:375EX21:378Pharmaceutical
    This companySectorCustomersSubsidiaries

    Evidence & claims

    From filings & derived data
    • Capex (YoY) (2026-03-31 vs 2025-03-31): 35.9%Derived (calculated)
    • Revenue (YoY) (2026-03-31 vs 2025-03-31): -4.3%Derived (calculated)
    • Net income (YoY) (2026-03-31 vs 2025-03-31): -11.3%Derived (calculated)
    • Gross profit (YoY) (2026-03-31 vs 2025-03-31): -6.1%Derived (calculated)
    • Net margin (FY 2026-03-31): 17.5%Derived (calculated)
    • Gross margin (FY 2026-03-31): 54.7%Derived (calculated)
    • EPS (diluted) (YoY) (2026-03-31 vs 2025-03-31): -8.9%Derived (calculated)
    • EPS (basic) (YoY) (2026-03-31 vs 2025-03-31): -9.0%Derived (calculated)
    • Cost of revenue (YoY) (2026-03-31 vs 2025-03-31): -2.0%Derived (calculated)
    • Operating income (YoY) (2026-03-31 vs 2025-03-31): -8.1%Derived (calculated)
    • Operating cash flow (YoY) (2026-03-31 vs 2025-03-31): 2.4%Derived (calculated)
    • Capex (annual): USD 11.18MSEC XBRL filing
    • Cost of revenue (annual): USD 493.13MSEC XBRL filing
    • Net income (annual): USD 190.3MSEC XBRL filing
    • Total operating expenses (annual): USD 286.17MSEC XBRL filing
    • Operating cash flow (annual): USD 257.63MSEC XBRL filing
    • Pre-tax income (annual): USD 257.5MSEC XBRL filing
    • Operating income (annual): USD 309.41MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES 4SEC XBRL filing
    • Gross profit (annual): USD 595.58MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 4SEC XBRL filing
    • Revenue (annual): USD 1.09BSEC XBRL filing
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 8.1%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 4.2%Derived (calculated)
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-08-06EVENTUpcomingQ1 2027 earnings (confirmed · filed)
    2026-07-07 04:39 UTCFILINGMaterial 8-K
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-26 03:13 UTCHOLDERInstitutional holding changed
    2026-06-26 03:13 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-25 03:10 UTCHOLDERInstitutional holding changed
    2026-06-25 03:10 UTCHOLDER1 institutional position change flagged (1 major)
    2026-06-16FILINGFORM 8-K →
    2026-05-14FILING10-K filing →
    2026-05-13FILING8-K filing →
    2026-05-11 00:00 UTCINSIDER31 insider transactions — 2026-05 · net sell $2.2M
    2026-05-11INSIDERZerillo Jeffrey sold 351 sh Common Stock, par value $0.01 per share — Senior VP Operations ~$18k
    2026-05-07INSIDERLombardi Ronald M. transacted 2.5k sh Common Stock, par value $0.01 per share — Director, Chief Executive Officer ~$139k
    2026-05-07INSIDERMekhail Adel transacted 487 sh Common Stock, par value $0.01 per share — EVP, Marketing & Sales ~$27k
    2026-05-07INSIDERZerillo Jeffrey transacted 351 sh Common Stock, par value $0.01 per share — Senior VP Operations ~$19k
    2026-05-07INSIDERZerillo Jeffrey sold 305 sh Common Stock, par value $0.01 per share — Senior VP Operations ~$17k
    2026-05-07INSIDERSacco Christine transacted 991 sh Common Stock, par value $0.01 per share — CFO & COO ~$54k
    2026-05-05INSIDERZerillo Jeffrey sold 1.2k sh Common Stock, par value $0.01 per share — Senior VP Operations ~$66k
    2026-05-05INSIDERZerillo Jeffrey transacted 307 sh Common Stock, par value $0.01 per share — Senior VP Operations ~$17k
    2026-05-05INSIDERSacco Christine transacted 1.3k sh Common Stock, par value $0.01 per share — CFO & COO ~$71k
    2026-05-05INSIDERZerillo Jeffrey sold 346 sh Common Stock, par value $0.01 per share — Senior VP Operations ~$19k
    2026-05-05INSIDERLombardi Ronald M. transacted 2.2k sh Common Stock, par value $0.01 per share — Director, Chief Executive Officer ~$122k
    2026-05-04INSIDERMekhail Adel transacted 4.0k sh Common Stock, par value $0.01 per share — EVP, Marketing & Sales
    2026-05-04INSIDERLombardi Ronald M. transacted 31.5k sh Common Stock, par value $0.01 per share — Director, Chief Executive Officer
    2026-05-04INSIDERLombardi Ronald M. transacted 19.7k sh Common Stock, par value $0.01 per share — Director, Chief Executive Officer
    2026-05-04INSIDERLombardi Ronald M. transacted 16.8k sh Common Stock, par value $0.01 per share — Director, Chief Executive Officer ~$929k
    2026-05-04INSIDERSacco Christine transacted 7.0k sh Common Stock, par value $0.01 per share — CFO & COO
    2026-05-04INSIDERSacco Christine transacted 3.4k sh Common Stock, par value $0.01 per share — CFO & COO ~$190k
    2026-05-04INSIDERSacco Christine transacted 12.0k sh Common Stock, par value $0.01 per share — CFO & COO
    2026-05-04INSIDERP'Pool William transacted 3.7k sh Common Stock, par value $0.01 per share — See Remarks
    2026-05-04INSIDERP'Pool William transacted 1.9k sh Common Stock, par value $0.01 per share — See Remarks ~$104k
    2026-05-04INSIDERP'Pool William transacted 4.2k sh Common Stock, par value $0.01 per share — See Remarks
    2026-05-04INSIDERZerillo Jeffrey transacted 2.5k sh Common Stock, par value $0.01 per share — Senior VP Operations
    2026-05-04INSIDERZerillo Jeffrey transacted 1.2k sh Common Stock, par value $0.01 per share — Senior VP Operations ~$69k
    2026-05-04INSIDERZerillo Jeffrey transacted 2.9k sh Common Stock, par value $0.01 per share — Senior VP Operations
    2026-05-04INSIDERMekhail Adel transacted 3.5k sh Common Stock, par value $0.01 per share — EVP, Marketing & Sales
    2026-05-01 15:54 UTCFILINGRegulatory filing →
    2026-03-20FILINGFORM 8-K →
    2026-02-11 00:00 UTCINSIDER1 insider transaction — 2026-02
    Showing the 40 most recent of 57 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage